Abstract U937 cells were found to be activated by an antibacterial peptide, KLKLLLLLKLK-NH 2 (L5), to generate superoxide anion ( )-like peripheral neutrophils. However, the state of cell surface calreticulin, a possible receptor Ϫ O 2 for L5, was suggested to differ between neutrophils and U937 cells. Unlike the former, the latter ones were activated by anti-C-domain peptide antibody of calreticulin even in the absence of L5 and generated in a GTP-binding protein
INTRODUCTION
Recently, we found that a synthetic peptide, KLKLLLLLKLK-NH 2 (L5), showed significant chemotherapeutic activity in methicillin-resistant Staphylococcus aureus (MRSA)-infected mice, whereas another peptide, KLKLLLKLK-NH 2 (L3), did not, although antibacterial activity of the L3 was higher than that of L5 when assayed in vitro (Nakajima et al 1997) . We found that L5, but not L3, had the ability to activate human neutrophils to produce (Cho et al 1999) . Therefore, the chemo-Ϫ O 2 therapeutic activity of these two peptides was assumed to be related to their neutrophil-activating activity. The activation of human neutrophils by L5 was inhibited by pertussis toxin (PTX), suggesting that GTP-binding protein (G-protein) participates in this process. We isolated an L5-binding protein with a molecular mass of 60 kDa from neutrophil membranes, which turned out to be human calreticulin (Cho et al 1999) .
Calreticulin is a multifunctional calcium-binding protein with an endoplasmic reticulum (ER) retrieval sequence, KDEL, in its C-terminal region (McCauliffe et al 1992; Nash et al 1994; Krause et al 1997) . It is assumed to be a molecular chaperone for MHC class I antigen (Sadasivan et al 1996; Van Leeuwen and Kearse 1996; Zhang and Salter 1998; Arosa et al 1999) . However, there have been several papers suggesting extracellular functions of calreticulin (Dupuis et al 1993; Dedhar 1994) . From the experiments using anticalreticulin antibody, we proposed that calreticulin is partly localized on the surface of neutrophils and functions as a receptor for L5 (Cho et al 1999) .
This paper reports cell surface calreticulin of retinoic acid-treated U937 cells. We found that, like peripheral neutrophils, retinoic acid-treated U937 cells were activated by L5 via their cell surface calreticulin, but the data suggested that the state of the C-terminal domain of U937 calreticulin is somehow different from that of neutrophil calreticulin.
MATERIAL AND METHODS

Culture and treatment of cells
U937 cells were suspended in RPMI 1640 (Gibco BRL, Rockville, MD, USA) containing 10% fetal bovine serum at a density of 2ϳ3 ϫ 10 5 cells/mL and then cultured for 3 days in the presence of 1 M retinoic acid (Sigma, St Louis, MO, USA). Then the cells were collected, washed, and suspended in an appropriate buffer for use. Cell viability was determined by trypan blue exclusion, which was consistently over 90%. Retinoic acid-treated U937 cells were used throughout the subsequent experiments.
Measurement of generation
generation was measured according to a modification Ϫ O 2 of the procedure as described previously (Tomita et al 1984) . Freshly prepared U937 cells (10 6 ) were suspended in 1 mL of phenol red-free Dulbecco's Modified Eagle Medium (D-MEM, Gibco BRL), and then lucigenin (Sigma) was added to a final concentration of 0.1 mM. The cell suspension was incubated at 37ЊC for 5 minutes, and then test samples, to activate the U937 cells, were added. The generated was detected by measuring superoxide Ϫ O 2 dismutase (SOD)-sensitive and lucigenin-dependent chemiluminescence in a BIOLUMAT LB9505 (EG&G Berthold, Wellesley, MA, USA) at 37ЊC.
Preparation of membranes and solubilization of membrane proteins
Membranes were prepared from U937 cells according to a modification of the procedure as described previously (Williamson et al 1988) . Briefly, U937 cells were suspended at 10 8 cells/mL in PBS (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , pH 7.4) supplemented with 0.1 mM EGTA, 2 g/mL leupeptin, 1 g/mL pepstatin, and 1 mM phenylmethylsulfonyl fluoride, and then disrupted with a microtip probe sonicator for 10 seconds at 4ЊC. The resulting homogenate was layered over 25% sucrose in PBS containing 0.1 mM dithiothreitol (DTT), followed by centrifugation at 500 ϫ g for 15 minutes. The supernatant was layered again over 30% sucrose, followed by centrifugation at 90 000 ϫ g for 30 minutes. Membranes banded at the interphase were collected; pelleted by centrifugation at 150 000 ϫ g for 30 minutes; suspended in 10 mM HEPES-NaOH buffer (pH 7.4) containing 150 mM NaCl, 5 mM KCl, and 1 mM EGTA at 5-7 mg/mL protein; and then stored at Ϫ80ЊC until ready for use. Membrane proteins were solubilized by treating the membrane suspension with 1% Triton X-100.
Preparation of anticalreticulin antibodies
The antibodies used were the same as described previously (Cho et al 1999) . Two peptides corresponding to amino acid residues 54-73 of the N-domain and residues 399-417 of the C-domain of human calreticulin were chemically synthesized. Female New Zealand white rabbits were immunized with each peptide coupled with keyhole limpet hemocyanin, and each antibody was affinity purified.
Western blotting analysis of calreticulin
This was performed essentially as described previously (Cho et al 1999) . Proteins separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were electrophoretically transferred to a polyvinylidene difluoride microporous membrane (PVDF, Immunobilon, pore size 0.45 m, Millipore, Yvelines, France). The membrane was successively treated with affinity-purified antibodies against calreticulin and radioiodinated goat anti-rabbit IgG (3.7 kBq/ml, Amersham Pharmacia Biotech, Piscataway, NJ, USA) and then subjected to autoradiography.
RESULTS
In a previous study, we demonstrated that L5, but not L3, activated human peripheral neutrophils to produce Ϫ O 2 (Cho et al 1999) . The same was true for U937 cells (Fig  1) . The production of was detected only when U937 In order to confirm this, we examined the effect of anticalreticulin antibodies on the activation of U937 cells by L5. U937 cells were preincubated with the affinity-purified antibodies for 15 minutes and then treated with L5 to examine generation. The results were clearly dif- Activation of neutrophils by L5 was found to be coupled with G-protein, suggesting that calreticulin somehow interacts with G-protein. As pretreatment of U937 cells with anti-C-domain peptide antibody extremely enhanced generation by L5, it is expected that the anti-Ϫ O 2 body alone is sufficient for the activation of U937 cells even in the absence of L5. Therefore, we examined whether the antibody alone enhanced generation and Ϫ O 2 whether the enhancement was inhibited by PTX. As shown in Figure 3 , the addition of anti-C-domain peptide antibody alone to U937 cells activated the cells to generate O 2 , but when the cells were pretreated with PTX, the antibody no longer activated them. These results suggest that the binding of anti-C-domain peptide antibody to cell surface calreticulin causes the transmission of a signal to the cells via G-protein and thereby triggers Ϫ O 2 generation. This signal transduction pathway that lies downstream of calreticulin is assumed to be the same as that activated by L5.
Although it is clear that anti-C-domain peptide antibody activated U937 cells, there remains a possibility that this antibody preferentially recognizes a membrane protein other than calreticulin and that this protein is responsible for the signal transduction. To examine this possibility, we performed immunoblotting using anti-Cdomain peptide antibody. For this, we prepared a cell homogenate and detergent-soluble membrane proteins and subjected them to immunoblotting. A single protein band corresponding to a molecular mass of 60 kDa was detected in both fractions (Fig 4) . As exactly the same results were obtained with anti-N-domain peptide antibody (data not shown), we concluded that this protein is calreticulin, and probably calreticulin is the only membrane protein that reacts with anti-C-domain peptide antibody. We performed indirect immunofluorescence study using anti-C-domain peptide antibody to localize membrane calreticulin. As a cytoplasmic protein negative control, we treated the cells with anti-heat shock cognate (hsc) 73 monoclonal antibody, NT22 (Tsuboi et al 1994) . Contrary to the immunofluorescence of hsc73, an intracellular protein, clear fluorescence was detected when the cells were treated with anti-C-domain peptide antibody (Fig 5) , indicating that calreticulin is in fact localized on the surface of U937 cells. No appreciable signal was detected with control IgG (data not shown). We repeated the same experiment with anti-N-domain peptide antibody and obtained the same immunofluorescence results (data not shown), suggesting that both antibodies reacted with U937 cell surface expressed calreticulin almost in the same way.
DISCUSSION
Previously, we pointed out, for the first time, the novel function of calreticulin as a peptide receptor (Cho et al Immunofluorescence study of calreticulin on the surface of U937 cells. U937 cells were incubated in PBS containing 1% fetal calf serum for 40 minutes at 4ЊC. The cells were then successively treated with affinity-purified anti-C-domain peptide antibody and fluorescein isothiocyanate (FITC)-conjugated anti-rabbit IgG (A), as described previously (Cho et al 1999) . As a control for the immunofluorescence of intracellular protein, the cells were treated with the NT22 (antibody against hsc73) (B). 1999). Namely, L5 was shown to activate human peripheral neutrophils via cell surface calreticulin. The present results confirmed the participation of calreticulin in the signal transduction via G-protein in U937 cells. However, nothing is known about the state of cell surface calreticulin. Calreticulin has to be anchored to the cell surface in some way, as it lacks a transmembrane domain. Our previous results suggested that calreticulin is not a glycosylated phosphatidylinositol (GPI)-anchored protein.
Furthermore, it has to interact with G-protein directly or indirectly.
We demonstrated that anti-N-domain peptide antibody inhibited the receptor activity of calreticulin for L5, but anti-C-domain peptide antibody markedly stimulated the receptor activity even in the absence of L5. When examined with peripheral neutrophils, both antibodies inhibited the receptor activity, as reported previously (Cho et al 1999) . Possibly, the state of cell surface calreticulin differs between neutrophils and U937 cells. In particular, the state of the region corresponding to residues 399-417 (Cdomain peptide) seems to be critical. On the binding of antibody to this region, the conformation of U937 calreticulin may change to transmit a signal without the aid of L5, but this situation is different from in the case of neutrophil calreticulin. As the amino acid sequences of U937 and neutrophil calreticulins should be the same, the cell surface environment surrounding U937 calreticulin is assumed to be different from that surrounding neutrophil calreticulin. More biochemical studies are needed to clarify the difference in the state of cell surface calreticulin between neutrophils and U937 cells.
